Clinical Trial Update: Safety and Efficacy of PTH-IA [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating the safety and efficacy of PTH-IA for Jansen's metaphyseal chondrodysplasia is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Jansen Metaphyseal Chondrodysplasia

Drugs mentioned

• PTH-IA

Snippet

Sponsor: National Institute of Dental and Craniofacial Research (NIDCR) | Conditions: Jansen s Metaphyseal Chondrodysplasia | Phase 1, Phase 2 | Status: RECRUITING